NZ's disease-free sheep stomachs key to Aroa's success

NZ's disease-free sheep stomachs key to Aroa's success
Aroa CEO Brian Ward says the firm will stay in NZ, close to that sheep supply. (Image: Aroa Biosurgery)
Rebecca Stevenson
Soft tissue repair company Aroa says it has myriad reasons to be confident about its outlook with expansion of its Auckland manufacturing site, new machinery to boost output, a new device approved in the US and chunky product margins. Aroa Biosurgery is listed on the Australian securities exchange but has no plans to leave NZ with the country’s ample and uniquely disease-free stock of sheep guts underpinning the company’s output. Aroa has two sites near Auckland airport where it turns ovine abattoir leftovers into medical...

More Markets

91% of Tower’s new house policies are low flood risk
Markets

91% of Tower’s new house policies are low flood risk

Shareholders will get an increased dividend on top of a $45m capital return.

Ryman Healthcare’s previous interim profit turns into a loss with lower revaluations
Markets

Ryman Healthcare’s previous interim profit turns into a loss with lower revaluations

Ryman Healthcare’s previous $82 million profit has turned into a $45.1m loss after lower revaluations, but its boss says an important corner has been turned in its transformation with the balance sheet reset.The company today reported its half-year to Sept 30, 2025 result, compar...

Air NZ to airports: Stop subsidising Jetstar
Markets

Air NZ to airports: Stop subsidising Jetstar

Current airport regulation works against the national interest, Air NZ’s new CEO says.

Genesis sets out gas strategy
Markets

Genesis sets out gas strategy

Storage, Kupe’s long-term role and LNG flexibility anchor the plan.